Search results
Showing 6346 to 6360 of 7711 results
Artificial intelligence for analysing chest X-ray images (MIB292)
This medtech innovation briefing has been updated and replaced by health technology evaluation guidance on artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment (HTE12).
Daylight for treating generalised anxiety disorder in adults (MIB309)
August 2023: This medtech innovation briefing (MIB) has been withdrawn at the company’s request as the evidence for the technology has moved on and the company expect to seek a NICE guidance output in due course.
Abicipar pegol for treating wet age-related macular degeneration ID1533
In development [GID-TA10511] Expected publication date: TBC
Durvalumab for treating metastatic urothelial bladder cancer after chemotherapy [ID1172]
Discontinued [GID-TA10394]
Bevacizumab for untreated malignant pleural mesothelioma [ID1183]
Discontinued [GID-TA10197]
Discontinued [GID-TA10149]
Atezolizumab in combination for untreated squamous non-small-cell lung cancer [ID1481]
Discontinued [GID-TA10546]
Depatuxizumab mafodotin in combination for untreated EGFR-amplified glioblastoma multiforme [ID1466]
Discontinued [GID-TA10355]
Clofarabine for treating acute lymphoblastic leukaemia in children after 2 therapies [ID1033]
Discontinued [GID-TA10081]
Nelarabine for treating refractory T-cell lymphoblastic non-Hodgkin's lymphoma [ID1044]
Discontinued [GID-TA10087]
Discontinued [GID-QS10108]
Discontinued [GID-SGWAVE0702]
Discontinued [GID-MT117]